With the analysis among 251 patents, we discovered top 100 key players by total patent application. Boehringer Ingelheim (Canada) Ltd., UCB SA, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 18.73% of the total patent filing.
Boehringer Ingelheim (Canada) Ltd.
Ontario, Canada
Patent: 20
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 15
F. Hoffmann-La Roche Ltd.
Gan & Lee Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 11
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 9
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 9
Nordrhein-Westfalen, Germany
Patent: 7
E-nitiate Biopharmaceuticals (Hangzhou) Co.,Ltd
With the analysis among 11 patents, we discovered top 3 start-ups by total patent application.
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 9
Institut National de la Santé et de la Recherche Médicale
Escient Pharmaceuticals, Inc.
California, United States
Patent: 1
With the analysis among related 67 patents applied in the last 5 years. We discover 40 most active companies in this area. The fast-growing Chengdu Hyperway Pharmaceuticals Co., Ltd., Shenzhen Haibowei Pharmaceutical Co., Ltd., E-nitiate Biopharmaceuticals (Hangzhou) Co.,Ltd take 37.31% of patent filing during this period.
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 9
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 9
E-nitiate Biopharmaceuticals (Hangzhou) Co.,Ltd
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Gan & Lee Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 5
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 2
Manitoba, Canada
Patent: 2
With the analysis among related 67 patents in last 5 years, we discover 37 new entrants. Chengdu Hyperway Pharmaceuticals Co., Ltd., Shenzhen Haibowei Pharmaceutical Co., Ltd., E-nitiate Biopharmaceuticals (Hangzhou) Co.,Ltd are the most active new entrants in this area.
Chengdu Hyperway Pharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 9
Shenzhen Haibowei Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 9
E-nitiate Biopharmaceuticals (Hangzhou) Co.,Ltd
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 2
Manitoba, Canada
Patent: 2
Sichuan Sheng, China
Patent: 2
With the analysis among 45 patents, we discovered top 23 universities and scientific research institutions by total patent application. The Scripps Research Institute, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Eberhard Karls Universität Tübingen are dominant in this area. They take 33.33% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 6
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
North Carolina, United States
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Australian National University
Australian Capital Territory, Australia
Patent: 2
Sichuan Sheng, China
Patent: 2
Central China Normal University
Hubei Sheng, China
Patent: 2
Manitoba, Canada
Patent: 2
China Agricultural University
Beijing Shi, China
Patent: 1